Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
Other Sites
- tummy tuck cost
- tummy tuck surgery
- breast enhancement
- saline breast implants
- Affordable medical tourism
- Boob job cost
- lower blepharoplasty
- What is medical tourism
- medical tourism companies
- breast augmentation surgery
- Calf implants
- Breast lift and augmentation
- abdominoplasty surgery cost
- breast enlargement surgery
- How much do breast implants cost
- body contouring surgery
- breast implant cost
- celebrity plastic surgery
- how much are breast implants
- The Truth about Silicone Breast Implants
Category Archives: Cell Medicine
NY medical schools chart progress with stem cells
Almost halfway through a $600 million state program supporting stem cell research, eight medical schools around New York are reporting progress on projects such as replicating liver cells and eradicating leukemia cells. Continue reading
Posted in Cell Medicine
Tagged 600-million, and-eradicating, are-reporting, cell-research-, eight-medical, halfway-through, leukemia-cells-, progress-on-projects, projects-such, schools-around, such-as-replicating, supporting-stem
Comments Off
Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell …
NEW YORK, May 7, 2012 /PRNewswire/ –Islet Sciences, Inc., (ISLT.OB) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has exclusively licensed technology from Yale University. “In the course of research conducted under Yale auspices, Dr. Kevan Herold and his colleagues at Yale University School of Medicine have developed a technology entitled ‘Circulating hypomethylated B cell-derived DNA’ as a biomarker of B cell destruction,” said John Steel, Chairman and CEO of Islet Sciences. Continue reading
Posted in Cell Medicine
Tagged a-cells-form, active-capital, development, dna, groundbreaking, medicine, research, resources-group, securities, technology-, university, york
Comments Off
New type of cell with a key role in treatment-resistant asthma
ScienceDaily (May 7, 2012) For most people with asthma, a couple of puffs from an inhaler filled with steroids makes breathing easy. But if their lungs become resistant to the calming effect of that medicine, they live in fear of severe asthma attacks that could send them to the hospital — or worse. Now, new research from the University of Michigan Health System may help explain what’s going on in the lungs of these steroid-resistant individuals. Continue reading
Posted in Cell Medicine
Tagged asthma, blood, bryan-petersen, cells, medical, michigan-health, nicholas-lukacs, science
Comments Off
Advanced Cell Technology to Host Conference Call to Discuss 2012 First Quarter Results and Provide Corporate Update on …
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will hold an earnings call on Wednesday, May 9th,at 9 a.m. EDT during which it will discuss 2012 first quarter results for the period ended March 31, 2012 and provide a corporate update. Continue reading
Posted in Cell Medicine
Tagged a-the-same, access-the-call, advanced-cell, based-on-the, circumstances, development, field, intellectual, news, private, statements, technology-, time, words
Comments Off
Aged hematopoietic stem cells rejuvenated to be functionally younger
Public release date: 3-May-2012 [ | E-mail | Share ] Contact: Nick Miller nicholas.miller@cchmc.org 513-803-6035 Cincinnati Children’s Hospital Medical Center CINCINNATI Researchers have rejuvenated aged hematopoietic stem cells to be functionally younger, offering intriguing clues into how medicine might one day fend off some of the ailments of old age. Scientists at Cincinnati Children’s Hospital Medical Center and the Ulm University Medicine in Germany report their findings online May 3 in the journal Cell Stem Cell. The paper brings new perspective to what has been a life science controversy countering what used to be broad consensus that the aging of hematopoietic stem cells (HSCs) was locked in by nature and not reversible by therapeutic intervention Continue reading
Posted in Cell Medicine
Tagged a-life-science, a-natural-life, aging, biology, cdc42, cells, cincinnati, department, disorganization, division, immune, journal, research
Comments Off
ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration …
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that Massachusetts Eye and Ear (Mass. Eye and Ear) has received institutional review board (IRB) approval to be a site for the companys Phase I/II clinical trial for dry age-related macular degeneration (dry AMD), using human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells Continue reading
Posted in Cell Medicine
Tagged a-site-for, advanced-cell, clinical, harvard-medical, hesc, information, international, mass--, retina, retina-service, safety, technology-, united-states
Comments Off
Alliance for Regenerative Medicine Holds Clinical Outlooks for Regenerative Medicine Meeting in Partnership With …
WASHINGTON, DC–(Marketwire -05/03/12)- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced it will hold a conference titled, Clinical Outlooks for Regenerative Medicine 2012, in partnership with Harvard Stem Cell Institute on June 19, 2012. The meeting, being held at The Starr Center, Schepens Eye Research Institute, 185 Cambridge Street, Boston, MA, will assemble a group of ~200 leading regenerative medicine executives, clinicians and investigators from major research establishments and companies to discuss how these technologies are transforming the practice of medicine Continue reading
Posted in Cell Medicine
Tagged boston-, cambridge, harvard, harvard-stem, industry, medical, medicine, president, professor, regenerative
Comments Off
Fibrocell Science Technology Leads to Discovery of Two Rare Adult Stem Cell-Like Subpopulations in Human Skin
EXTON, Pa.–(BUSINESS WIRE)– In collaboration with Fibrocell Science, Inc., (OTCBB:FCSC.OB), researchers at the University of California, Los Angeles (UCLA) have identified two rare adult stem cell-like subpopulations in adult human skin, a discovery that may yield further ground-breaking research in the field of personalized medicine for a broad range of diseases. Continue reading
Posted in Cell Medicine
Tagged california, diseases, fibrocell, method, regenerative, science, skin, university, within-the-skin
Comments Off
Genetically Modified T Cell Therapy Shown to be Safe, Lasting in Decade-Long Penn Medicine Study of HIV Patients
PHILADELPHIA HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. Continue reading
Posted in Cell Medicine
Tagged a-framework-for, dna, earlier, hiv, medicine, science, study, university, virus
Comments Off
Bio-Matrix Subsidiary "First in Class" Approach to Stem Cell Medicine
SAN DIEGO, CA–(Marketwire -05/03/12)- Regen BioPharma (Regen), Inc. a newly-formed subsidiary of Bio-Matrix Scientific Group, Inc. Continue reading
Posted in Cell Medicine
Tagged academia-given, agencies-regen, development, regen, san, space, spun-off-either, through-the-fda
Comments Off